Aripiprazole as related to Schizophrenia

• ABILIFY® (aripiprazole) - A Treatment for Bipolar I Disorder and ...
  Learn about ABILIFY, a medication for the treatment of schizophrenia and manic episodes associated with Bipolar I Disorder.
  
  
• ABILIFY® (aripiprazole)—a Prescription Medication for the Treatment ...
  Learn more about ABILIFY—a prescription medication for the treatment of schizophrenia. ... ABILIFY ® (aripiprazole) is a prescription medicine for the treatment of schizophrenia ...
  
  
• Aripiprazole, Abilify - Atypical Antipsychotic for Schizophrenia and ...
  In-depth information on Aripiprazole, Abilify, an atypical antipsychotic - includes usage, dosage, adverse reactions of Aripiprazole, Abilify and news articles.
  
  
• Aripiprazole for schizophrenia
  El-Sayeh HG, Morganti C. Aripiprazole for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD004578. DOI: 10.1002/14651858.CD004578.pub3
  
  
• Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical ...
  Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials This study is ongoing, but not recruiting participants.
  
  
• Aripiprazole in Schizophrenia: Consensus Guidelines
  From International Journal of Clinical Practice Aripiprazole in Schizophrenia: Consensus Guidelines. Posted 09/30/2005. M. J. Travis; T.
  
  
• Aripiprazole in Schizophrenia: Consensus Guidelines
  Implications in Practice Which Patients May Benefit from Aripiprazole? Aripiprazole was licensed for use in the EU in June 2004, and it may be considered in the treatment of ...
  
  
• Aripiprazole - Wikipedia, the free encyclopedia
  Aripiprazole (produced by Otsuka Pharmaceutical Co. and sold as Abilify ) was approved by the Food and Drug Administration (FDA) on November 15, 2002 for the treatment of schizophrenia , the sixth atypical antipsychotic medication of its kind. More recently it received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder , as well as treatment of depression . Aripiprazole was developed by Otsuka in Japan; in the U.S., Otsuka America markets the drug jointly with Bristol Meyers Squibb.
  Pharmacology · Pharmacokinetics · Metabolism · Adverse events · Dosage forms
  
  
• Aripiprazole
  Aripiprazole is a drug that is licensed to treat bipolar disorder, schizophrenia, and depression. This eMedTV article discusses aripiprazole uses in more detail, explains how the ...
  
  
• Aripiprazole for Schizophrenia - User ratings & reviews - Revolution ...
  User ratings and reviews for drugs, medications, treatments, herbs, vitamins and conditions ... About Revolution treatment ratings. This service is in its infancy, but our ...